21-46430241-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.7913+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0908 in 1,608,684 control chromosomes in the GnomAD database, including 12,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 4500 hom., cov: 33)
Exomes 𝑓: 0.082 ( 7742 hom. )

Consequence

PCNT
NM_006031.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.337
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 21-46430241-G-C is Benign according to our data. Variant chr21-46430241-G-C is described in ClinVar as [Benign]. Clinvar id is 138608.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46430241-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.434 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.7913+9G>C intron_variant Intron 36 of 46 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.7559+9G>C intron_variant Intron 36 of 46 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.7913+9G>C intron_variant Intron 36 of 46 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27095
AN:
152058
Hom.:
4494
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.440
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0942
Gnomad ASJ
AF:
0.0865
Gnomad EAS
AF:
0.00559
Gnomad SAS
AF:
0.0902
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0762
Gnomad OTH
AF:
0.164
GnomAD2 exomes
AF:
0.0958
AC:
23762
AN:
247964
AF XY:
0.0904
show subpopulations
Gnomad AFR exome
AF:
0.450
Gnomad AMR exome
AF:
0.0548
Gnomad ASJ exome
AF:
0.0865
Gnomad EAS exome
AF:
0.00311
Gnomad FIN exome
AF:
0.109
Gnomad NFE exome
AF:
0.0747
Gnomad OTH exome
AF:
0.0827
GnomAD4 exome
AF:
0.0816
AC:
118900
AN:
1456508
Hom.:
7742
Cov.:
30
AF XY:
0.0807
AC XY:
58502
AN XY:
724686
show subpopulations
African (AFR)
AF:
0.462
AC:
15391
AN:
33312
American (AMR)
AF:
0.0593
AC:
2642
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.0849
AC:
2215
AN:
26096
East Asian (EAS)
AF:
0.00169
AC:
67
AN:
39672
South Asian (SAS)
AF:
0.0841
AC:
7235
AN:
86060
European-Finnish (FIN)
AF:
0.103
AC:
5465
AN:
52850
Middle Eastern (MID)
AF:
0.0738
AC:
366
AN:
4958
European-Non Finnish (NFE)
AF:
0.0719
AC:
79668
AN:
1108800
Other (OTH)
AF:
0.0972
AC:
5851
AN:
60178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
5512
11024
16536
22048
27560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3074
6148
9222
12296
15370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
27135
AN:
152176
Hom.:
4500
Cov.:
33
AF XY:
0.175
AC XY:
13005
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.439
AC:
18217
AN:
41464
American (AMR)
AF:
0.0940
AC:
1438
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0865
AC:
300
AN:
3470
East Asian (EAS)
AF:
0.00560
AC:
29
AN:
5180
South Asian (SAS)
AF:
0.0900
AC:
434
AN:
4820
European-Finnish (FIN)
AF:
0.107
AC:
1134
AN:
10620
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0761
AC:
5177
AN:
68002
Other (OTH)
AF:
0.167
AC:
353
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
945
1890
2834
3779
4724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0745
Hom.:
232
Bravo
AF:
0.189
Asia WGS
AF:
0.104
AC:
362
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 26, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Microcephalic osteodysplastic primordial dwarfism type II Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.4
DANN
Benign
0.35
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1023160; hg19: chr21-47850155; COSMIC: COSV64029129; COSMIC: COSV64029129; API